Skip to main content
. 2024 May 24;8(3):308–320. doi: 10.1016/j.mayocpiqo.2024.04.004

Figure 2.

Figure 2

Distribution of fills for buprenorphine by days supply, February 2019-May 2023 for commercial (A) and medicare advantage (B). The moving average rate ratio is calculated with respect to January-March 2019; shaded areas represent 95% CIs. COVID-19, coronavirus disease.